Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients

被引:302
作者
Colodner, R [1 ]
Rock, W
Chazan, B
Keller, N
Guy, N
Sakran, W
Raz, R
机构
[1] HaEmek Med Ctr, Clin Microbiol Lab, IL-18101 Afula, Israel
[2] HaEmek Med Ctr, Infect Dis Unit, IL-18101 Afula, Israel
[3] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[4] HaEmek Med Ctr, Dept Family Med, IL-18101 Afula, Israel
[5] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
关键词
D O I
10.1007/s10096-003-1084-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Although the risk factors for acquiring infection by extended-spectrum beta-lactamase (ESBL)-producing bacteria have been investigated in hospitalized patients, such risk factors have not been defined in the community setting. In this study, clinical data from a total of 311 nonhospitalized patients with community-acquired urinary tract infection (128 with ESBL-positive strains and 183 with ESBL-negative strains) were obtained. According to a multivariate analysis, the following were identified as independent risk factors: previous hospitalization in the past 3 months (OR=8.95, 95%CI, 3.77-21.25), antibiotic treatment in the past 3 months (OR=3.23, 95%CI, 1.76-5.91), age over 60 years (OR=2.65, 95%CI, 1.45-4.83), diabetes (OR=2.57, 95%CI, 1.20-5.51), male gender (OR=2.47, 95%CI, 1.22-5.01), Klebsiella pneumoniae infection (OR=2.31, 95%CI, 1.17-4.54), previous use of third-generation cephalosporins (P=0.014, OR=15.8, 95%CI, 1.7-143), previous use of second-generation cephalosporins (P<0.0001, OR=10.1, 95%CI, 4.2-24), previous use of quinolones (P=0.001, OR=4.1, 95%CI, 1.8-9.0), and previous use of penicillin (P=0.003, OR=4.0, 95%CI, 1.6-9.0).
引用
收藏
页码:163 / 167
页数:5
相关论文
共 19 条